These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22064071)

  • 21. Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.
    Nozaki I; Watanabe T; Kawaguchi M; Akatsu H; Tsuneyama K; Yamamoto Y; Ohe K; Yonekura H; Yamada M; Yamamoto H
    Arch Histol Cytol; 2007 Dec; 70(5):279-90. PubMed ID: 18431028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
    Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME
    FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
    Kojro E; Postina R
    J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
    Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
    Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.
    Liu H; Xing A; Wang X; Liu G; Li L
    Neurobiol Aging; 2012 Apr; 33(4):826.e31-42. PubMed ID: 21813211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression.
    Cuevas E; Lantz SM; Tobón-Velasco JC; Newport GD; Wu Q; Virmani A; Ali SF; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):288-96. PubMed ID: 21216281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
    Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
    J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures.
    Lotz M; Ebert S; Esselmann H; Iliev AI; Prinz M; Wiazewicz N; Wiltfang J; Gerber J; Nau R
    J Neurochem; 2005 Jul; 94(2):289-98. PubMed ID: 15998280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
    Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
    Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice.
    Liu LP; Hong H; Liao JM; Wang TS; Wu J; Chen SS; Li YQ; Long Y; Xia YZ
    Synapse; 2009 Aug; 63(8):636-42. PubMed ID: 19347957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
    Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
    Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
    Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
    Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE).
    Han YT; Kim K; Choi GI; An H; Son D; Kim H; Ha HJ; Son JH; Chung SJ; Park HJ; Lee J; Suh YG
    Eur J Med Chem; 2014 May; 79():128-42. PubMed ID: 24727489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Watanabe T; Yamamoto H
    J Pharmacol Sci; 2005 Mar; 97(3):305-11. PubMed ID: 15750291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.